Archive for the ‘Gynaecology & Obs’ Category
Lack of sexual interest is the most common sexual complaint in women
Posted by: admin on: August 2, 2011
The latest version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), which defines psychiatric disorders, defines Hypoactive Sexual Desire Disorder (HSDD) as ‘‘persistently or recurrently deficient (or absent) sexual fantasies and desire for sexual activity’’ that causes ‘‘marked distress or interpersonal difficulty. ’’ Epidemiologic surveys have suggested that from 25 to 50 percent […]
Menopause and cancer: What women should know
Posted by: admin on: July 22, 2011
Menopause often brings more than physical changes. It also may bring uncertainty about cancer risks and cancer prevention. How does menopause affect a woman’s cancer risk? Menopause does not cause cancer. But your risk of developing cancer increases as you age. So women going through menopause have a greater chance of developing cancer because they’re […]
How PCOS can be diagnosed and treated in primary care
Posted by: admin on: July 22, 2011
It is one of the most common causes of dysfunctional uterine bleeding, with a complaint of irregular periods being the most common presenting complaint to the doctor. The PCOS diagnostic criteria were developed by the National Institute of Health (NIH) in 1990, and include the following: 1. Hyperandrogenism: These women tend to have more androgen […]
Screening and Risk Assessment for Osteoporosis in Postmenopausal Women
Posted by: admin on: July 12, 2011
A direct comparison of the recommendations presented in the above guidelines for screening and risk assessment for osteoporosis in postmenopausal women is provided in the tables below. Areas of Agreement Risk Assessment All of the groups recommend an assessment for risk factors associated with osteoporosis and osteoporotic fracture. All adult patients ≥ age 50 (American […]
FDA Approves Second Folate-Boosted Oral Contraceptive
Posted by: admin on: June 29, 2011
Folate-Boosted Oral Contraceptive is intended to reduce the risk for rare neural tube defects in a pregnancy conceived during its use or shortly thereafter The US Food and Drug Administration (FDA) has approved an oral contraceptive Safyral in which 451 μg levomefolate calcium has been added to each tablet of a 21/7 drospirenone 3 mg/estradiol […]
Search
- drchasrani: Difficult to get such a data, authenticated at that. Try Times of India online library
- rakesh pore: hi, where can i get genuine information about "10 most common drugs sold in india?" i want it for a local project
- nilesh dutta: sir, Plz give detail about MBA Sports Management Thanks and Regards
